Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 450 participants.

Also called NCT05069558

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05069558
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Denmark, Finland, France, Germany, Netherlands, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05069558. Randomized; single masking; primary purpose treatment. Start 2022-05-09 (actual); primary completion 2025-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
Acronym
OCCLUFLEX
Condition
Stroke
Condition
Patent Foramen Ovale
Condition
PFO
Intervention (Device)
Investigational PFO Closure Device
Intervention (Device)
Standard of Care PFO Closure Device
Lead sponsor
Occlutech International AB (class: industry)

Record details

Record id
cardio:ct-nct05069558
Content hash
db4cef560ab4b20f6e13a853a7c2c3b0788222eba4a2b8a6cb8a618e08985243